Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02111291 · ClinicalTrials.gov registry record · Phase 4
Santyl Applications to Diabetic Foot Ulcers
A Phase 4 study, sponsored by Healthpoint.
- Completed
- Registry status
- Phase 4
- Development phase
- 215
- Enrollment target
NCT02111291 is a Phase 4 study that has completed, run by Healthpoint. The registered enrollment target is 215 participants.
The verdict
NCT02111291, a Phase 4 study, has completed, sponsored by Healthpoint.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 215 participants
- Enrollment target
Study Summary
The current trial examines the potential benefits of continuous 12 week treatment with Santyl, measured in terms of wound bed appearance. The visual appearance of granulation tissue will be recorded at each visit for the purpose of examining the relationship between wound bed appearance and progress towards healing. In support of this longer treatment regimen with Santyl, a recent animal study found that application of Santyl for 12 weeks was safe and well tolerated. Therefore, the present study is designed to test the hypothesis that daily treatment of diabetic foot ulcers (DFU) with Santyl for up to 12 weeks will result in more rapid development of granulation tissue than DFU treated with supportive care.
Interventions
- BIOLOGICAL Collagenase SANTYL® Ointment
- BIOLOGICAL Hydrogel (if needed) and foam dressing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 215 participants |
| Start Date | 2014-04 |
| Est. Completion | 2015-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02111291
The ClinicalTrials.gov registry entry for NCT02111291 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 215 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healthpoint, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Collagenase SANTYL® Ointment is the first listed.
NCT02111291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02111291 about?
NCT02111291 is a clinical study titled "Santyl Applications to Diabetic Foot Ulcers". The current trial examines the potential benefits of continuous 12 week treatment with Santyl, measured in terms of wound bed appearance. The visual appearance of granulation tissue will be recorded at each visit for the purpose of examining the relationship between wound bed appearance and progress...
What is the current status of trial NCT02111291?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 215 participants. The study started on 2014-04. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02111291?
The interventions under investigation include: Collagenase SANTYL® Ointment (BIOLOGICAL), Hydrogel (if needed) and foam dressing (BIOLOGICAL).
Who is sponsoring clinical trial NCT02111291?
This trial is sponsored by Healthpoint, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.